Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release
- PMID: 11518688
- DOI: 10.1152/ajpgi.2001.281.3.G752
Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release
Abstract
We investigated the effect of acarbose, an alpha-glucosidase and pancreatic alpha-amylase inhibitor, on gastric emptying of solid meals of varying nutrient composition and plasma responses of gut hormones. Gastric emptying was determined with scintigraphy in healthy subjects, and all studies were performed with and without 100 mg of acarbose, in random order, at least 1 wk apart. Acarbose did not alter the emptying of a carbohydrate-free meal, but it delayed emptying of a mixed meal and a carbohydrate-free meal given 2 h after sucrose ingestion. In meal groups with carbohydrates, acarbose attenuated responses of plasma insulin and glucose-dependent insulinotropic polypeptide (GIP) while augmenting responses of CCK, glucagon-like peptide-1 (GLP-1), and peptide YY (PYY). With mixed meal + acarbose, area under the curve (AUC) of gastric emptying was positively correlated with integrated plasma response of GLP-1 (r = 0.68, P < 0.02). With the carbohydrate-free meal after sucrose and acarbose ingestion, AUC of gastric emptying was negatively correlated with integrated plasma response of GIP, implying that prior alteration of carbohydrate absorption modifies gastric emptying of a meal. The results demonstrate that acarbose delays gastric emptying of solid meals and augments release of CCK, GLP-1, and PYY mainly by retarding/inhibiting carbohydrate absorption. Augmented GLP-1 release by acarbose appears to play a major role in the inhibition of gastric emptying of a mixed meal, whereas CCK and PYY may have contributory roles.
Similar articles
-
alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.Diabet Med. 2005 Apr;22(4):470-6. doi: 10.1111/j.1464-5491.2005.01451.x. Diabet Med. 2005. PMID: 15787675 Clinical Trial.
-
Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.Am J Physiol Gastrointest Liver Physiol. 2009 Mar;296(3):G482-9. doi: 10.1152/ajpgi.90209.2008. Epub 2008 Dec 24. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19109408 Clinical Trial.
-
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.Diabetes. 2005 Jul;54(7):2212-8. doi: 10.2337/diabetes.54.7.2212. Diabetes. 2005. PMID: 15983224
-
Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.Physiol Behav. 2001 Nov-Dec;74(4-5):735-41. doi: 10.1016/s0031-9384(01)00618-7. Physiol Behav. 2001. PMID: 11790437 Review.
-
Gut Hormones and Inflammatory Bowel Disease.Biomolecules. 2025 Jul 14;15(7):1013. doi: 10.3390/biom15071013. Biomolecules. 2025. PMID: 40723884 Free PMC article. Review.
Cited by
-
Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Open Heart. 2015 Jan 29;2(1):e000205. doi: 10.1136/openhrt-2014-000205. eCollection 2015. Open Heart. 2015. PMID: 25685364 Free PMC article. Review.
-
Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.Clin Interv Aging. 2014 Nov 18;9:1963-80. doi: 10.2147/CIA.S53482. eCollection 2014. Clin Interv Aging. 2014. PMID: 25429208 Free PMC article. Review.
-
Magnitude of slowing gastric emptying by glucagon-like peptide-1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes.J Diabetes Investig. 2020 Mar;11(2):389-399. doi: 10.1111/jdi.13115. Epub 2019 Jul 25. J Diabetes Investig. 2020. PMID: 31301103 Free PMC article.
-
A review of the efficacy and safety of oral antidiabetic drugs.Expert Opin Drug Saf. 2013 Mar;12(2):153-75. doi: 10.1517/14740338.2013.752813. Epub 2012 Dec 14. Expert Opin Drug Saf. 2013. PMID: 23241069 Free PMC article. Review.
-
Pre-Meal Whey Protein Alters Postprandial Insulinemia by Enhancing β-Cell Function and Reducing Insulin Clearance in T2D.J Clin Endocrinol Metab. 2023 Jul 14;108(8):e603-e612. doi: 10.1210/clinem/dgad069. J Clin Endocrinol Metab. 2023. PMID: 36734166 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources